To Evaluate the Efficacy and Safety of Netakimab in Chinese Patients With Moderate to Severe Plaque Psoriasis

Clinical trial NCT07008547 · COMPLETED

Trial details

NCT number: NCT07008547
Sponsor: SPH-BIOCAD (HK) Limited
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Plaque Psoriasis

Start date: 2024-07-30
Primary completion: 2025-03-28
Enrollment: 202

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.